DOP2010000075A - Compuesto inhibidor de glicógeno fosforilasa y composicion farmaceutica del mismo - Google Patents
Compuesto inhibidor de glicógeno fosforilasa y composicion farmaceutica del mismoInfo
- Publication number
- DOP2010000075A DOP2010000075A DO2010000075A DO2010000075A DOP2010000075A DO P2010000075 A DOP2010000075 A DO P2010000075A DO 2010000075 A DO2010000075 A DO 2010000075A DO 2010000075 A DO2010000075 A DO 2010000075A DO P2010000075 A DOP2010000075 A DO P2010000075A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- pharmaceutical composition
- gosphorilase
- glycrogen
- same
- inhibitor composite
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a un novedoso compuesto, el cual es un inhibidor de glicogeno fosforilasa y su uso en el tratamiento de diabetes y otras condiciones asociadas con el mismo. La invencion se refiere a una composicion farmaceutica conteniendo el compuesto y composicion farmaceutica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97586207P | 2007-09-28 | 2007-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2010000075A true DOP2010000075A (es) | 2010-07-15 |
Family
ID=40098462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2010000075A DOP2010000075A (es) | 2007-09-28 | 2010-03-11 | Compuesto inhibidor de glicógeno fosforilasa y composicion farmaceutica del mismo |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100305207A1 (es) |
EP (1) | EP2195287A1 (es) |
JP (1) | JP2010540552A (es) |
KR (1) | KR20100087300A (es) |
CN (1) | CN101932557A (es) |
AU (1) | AU2008309003A1 (es) |
BR (1) | BRPI0817721A2 (es) |
CA (1) | CA2701120A1 (es) |
CO (1) | CO6270306A2 (es) |
CR (1) | CR11398A (es) |
DO (1) | DOP2010000075A (es) |
EA (1) | EA201000391A1 (es) |
MA (1) | MA31776B1 (es) |
MX (1) | MX2010003440A (es) |
WO (1) | WO2009045830A1 (es) |
ZA (1) | ZA201002181B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
JPWO2013018735A1 (ja) | 2011-07-29 | 2015-03-05 | 大正製薬株式会社 | アミジン化合物又はその塩 |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP7307440B2 (ja) * | 2019-12-06 | 2023-07-12 | エスケイシー・カンパニー・リミテッド | 光学レンズ用ジイソシアネート組成物およびその調製方法 |
WO2021122645A1 (en) | 2019-12-20 | 2021-06-24 | Syngenta Crop Protection Ag | Pesticidally active azole-amide compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025157A1 (en) * | 1995-02-17 | 1996-08-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
CA2238298A1 (en) * | 1995-11-24 | 1997-06-19 | Luca Francesco Raveglia | Quinoline derivatives |
EP0906273B1 (en) * | 1996-05-24 | 2002-10-16 | Neurosearch A/S | Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
WO2004022525A1 (en) * | 2002-09-05 | 2004-03-18 | Neurosearch A/S | Amide derivatives and their use as chloride channel blockers |
EP1565429B1 (en) * | 2002-11-21 | 2009-05-13 | Neurosearch A/S | Diaryl ureido derivatives and their medical use |
JP2008519761A (ja) * | 2004-11-09 | 2008-06-12 | スミスクライン ビーチャム コーポレーション | グリコーゲンホスホリラーゼ阻害化合物およびその医薬組成物 |
-
2008
- 2008-09-25 EP EP08836758A patent/EP2195287A1/en not_active Withdrawn
- 2008-09-25 CA CA2701120A patent/CA2701120A1/en not_active Abandoned
- 2008-09-25 BR BRPI0817721-0A patent/BRPI0817721A2/pt not_active Application Discontinuation
- 2008-09-25 WO PCT/US2008/077624 patent/WO2009045830A1/en active Application Filing
- 2008-09-25 AU AU2008309003A patent/AU2008309003A1/en not_active Abandoned
- 2008-09-25 US US12/677,846 patent/US20100305207A1/en not_active Abandoned
- 2008-09-25 MX MX2010003440A patent/MX2010003440A/es not_active Application Discontinuation
- 2008-09-25 CN CN2008801179774A patent/CN101932557A/zh active Pending
- 2008-09-25 JP JP2010527129A patent/JP2010540552A/ja active Pending
- 2008-09-25 KR KR1020107009323A patent/KR20100087300A/ko not_active Application Discontinuation
- 2008-09-25 EA EA201000391A patent/EA201000391A1/ru unknown
-
2010
- 2010-03-11 DO DO2010000075A patent/DOP2010000075A/es unknown
- 2010-03-26 ZA ZA2010/02181A patent/ZA201002181B/en unknown
- 2010-03-26 CO CO10036338A patent/CO6270306A2/es not_active Application Discontinuation
- 2010-04-14 MA MA32771A patent/MA31776B1/fr unknown
- 2010-04-28 CR CR11398A patent/CR11398A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0817721A2 (pt) | 2015-03-31 |
EP2195287A1 (en) | 2010-06-16 |
CR11398A (es) | 2010-06-28 |
KR20100087300A (ko) | 2010-08-04 |
EA201000391A1 (ru) | 2010-10-29 |
CA2701120A1 (en) | 2009-04-09 |
MX2010003440A (es) | 2010-04-21 |
US20100305207A1 (en) | 2010-12-02 |
WO2009045830A1 (en) | 2009-04-09 |
CN101932557A (zh) | 2010-12-29 |
MA31776B1 (fr) | 2010-10-01 |
AU2008309003A1 (en) | 2009-04-09 |
JP2010540552A (ja) | 2010-12-24 |
ZA201002181B (en) | 2011-06-29 |
CO6270306A2 (es) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2010000075A (es) | Compuesto inhibidor de glicógeno fosforilasa y composicion farmaceutica del mismo | |
CR10748A (es) | Compuesto de indol | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
CL2011002787A1 (es) | Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica. | |
CL2008003116A1 (es) | Compuestos heterocíclicos bicíclicos; composición farmacéutica que comprende a dichos compuestos; y su uso en el tratamiento o prevención de enfermedades tales como diabetes, obesidad, trastorno metabólico, enfermedad cardiovascular entre otras. | |
BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
BR112012006346A2 (pt) | agonista de receptor de acetilcolina, composto, composição farmacêutica, combinação e uso de ativadores de receptor de acetilcolina nicotínico alfa 7 | |
CL2008001855A1 (es) | Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa. | |
CR11397A (es) | Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo | |
CL2008001049A1 (es) | Compuestos derivados de benzamidas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la diabetes, intolerancia a la glucosa, dislipidemia, hipertension, obesidad. | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
CL2008000690A1 (es) | Compuestos derivados del acido indol-3-propionico; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hiperlipidemia, hipertension; entre otras. | |
EA201200968A1 (ru) | Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин | |
CL2007002890A1 (es) | Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad. | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
EA201171246A1 (ru) | Содержащая трегалулозу композиция, ее получение и применение | |
CR11423A (es) | NUEVOS INHIBIDORES DE sEH Y SU USO | |
TN2010000074A1 (en) | Cyclic depsipeptides | |
MX2010001823A (es) | Piperidinil- y piperazinil-sulfonamidas biciclicas sustituidas utiles para inhibir 11beta-hidroxiesteroide deshidrogenasa tipo-1. | |
EA201201623A1 (ru) | Лечение диабета 2 типа | |
CL2008003546A1 (es) | Compuestos derivados de piridina; procedimiento de preparacion; composicion farmaceutica de dichos compuestos; y uso en el tratamiento y/o profilaxis de la diabetes mellitus tipo i y/o tipo ii. | |
CL2011000165A1 (es) | Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
HN2010000655A (es) | Benzotiazoles como moduladores del receptor de grelina | |
CL2011001777A1 (es) | Composicion farmaceutica que contiene aleglitazar; proceso para preparar dicha composicion farmaceutica; y su uso para el tratamiento o profilaxis de la diabetes tipo ii o enfermedades cardiovasculares. |